Carnegie Pharmaceuticals

Executive Summary

Carnegie Pharmaceuticals LLC is a privately-held specialty pharmaceutical company headquartered in Cambridge, Massachusetts, founded in 2018. The company focuses on developing generic and branded products with significant development barriers, particularly formulations targeting rare diseases. Carnegie differentiates itself through in-house manufacturing in the United States, ensuring quality control and supply chain reliability for global distribution. Its strategy centers on addressing unmet medical needs in niche therapeutic areas, leveraging expertise in complex formulations to create value.

Upcoming Catalysts (preview)

• Q3 2026Launch of a New Generic Product for a Rare Disease60% success
• H2 2026Announcement of a Licensing or Partnership Agreement40% success